Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
Dhargam Aljebouri, Laboratory Director at Clinical Immunology, Allergy and Transfusion Medicine – Specialized Immunosciences Laboratory, shared a post on LinkedIn:
”I was pleased to meet with Yaqoob Al-Mousawi, Director of the National Blood Transfusion Center, Baghdad, Iraq, together with colleagues, to discuss the scientific and organizational preparations for our upcoming International Society of Blood Transfusion (ISBT) Academy-supported educational activity: Advancing immunohematology and Transfusion Safety in Iraq: A One-Day Case-Based Educational Workshop for Transfusion Professionals
During the meeting, we reviewed the key components of the programme, including the scientific sessions, participant selection process, educational objectives, evaluation strategy and post-workshop learning follow-up.
This activity represents an important milestone for transfusion medicine education in Iraq, particularly as it is the first hashtag#ISBT Academy-supported educational activity in the country since the establishment of national blood transfusion services.
I am grateful to Yaqoob Al-Mousawi and the National Blood Transfusion Center for their leadership, support and commitment to strengthening professional education in transfusion medicine.
Looking forward to a meaningful and impactful educational day on 14 November 2026.
Dhargam Aljebouri
Scientific Coordinator and Lead Speaker.”
Stay updated with Hemostasis Today.
-
Oct 26, 2026, 03:43Shazmah Shaikh: How Laser Atherectomy Helps Clear Blocked Arteries
-
Oct 26, 2026, 03:28Priya Prasad: Protecting Donors and Recipients Through Blood Safety
-
Oct 25, 2026, 19:55Giacomo Buso: LIPLEG Provides the Strongest Evidence to Date on Lipedema Treatment
-
Oct 25, 2026, 19:54Nicholas Lee: ASH Program Connects Trainees and Faculty With Mentors for Career Development
-
Oct 25, 2026, 19:53World Thrombosis Day Raises Blood Clot Awareness at Italian Airports
-
Oct 25, 2026, 19:49Tahsim Anwar: A Six-Year Analysis of Adverse Events in Therapeutic Apheresis
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project